KPL-716

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPL-716, covering 2021-12-28 to 2021-12-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases [Phase 2]

See pricing